Slb Pharma

What Slb Pharma does

SLB Pharma is a privately held French Contract Research Organization (CRO) founded in 2007 and headquartered at 28 bis rue du Thabor, 35000 Rennes, France. The company is structured as a SARL (Société à Responsabilités Limitées) with SIREN 499315661 and capital social of €136,000, led by CEO Stéphanie Le Breton (PharmD). It operates as a full-service B2B CRO providing clinical research services for health product manufacturers across three core verticals: medical devices (CE marking under MDR 2017/745, post-market clinical follow-up), decentralized clinical trials (ECDs with telemedicine, eConsent, ePRO, and connected device telemonitoring), and nutraceuticals (efficacy, safety, tolerance studies supporting EFSA and HAS dossiers).

The company's technology stack centers on electronic clinical data capture, leveraging an eCRF platform hosted on Ennov Clinical, complemented by ePRO, eConsent, and connected medical device telemonitoring for decentralized protocols. It does not claim proprietary AI/ML systems but has accumulated operational expertise running validation studies for AI-enabled medical devices (e.g., OPHTAI-EVAL for Evolucare, Predictix antidepressant software study). Its core technical differentiator is its curated investigator network spanning French hospitals (CH/CHU), private clinics, liberal medical practices, pharmacies, and patient home care settings, enabling multidisciplinary recruitment across therapeutic areas including respiratory, dental, orthopedic, sleep, and digital health.

SLB Pharma's revenue model is professional-services based, generating income through custom-quoted, project-based contracts with multi-year billing cadences. Pricing varies by study design, number of sites, regulatory complexity, therapeutic area, and monitoring requirements. Go-to-market is sales-led, relying on direct outreach, website inquiries, professional network referrals, and participation in French clinical research associations (AFCROs, regional biotech clusters). Visible enterprise customers span medical device, dental, respiratory, home healthcare, and digital health sponsors (Air Liquide, Septodont, Acteon, FH Ortho, SpineVision, Evolucare, Vivisol, Biosency, Predictix, Blueback, Cerecare, Mexbrain, Elia Medical, abeye, Astensante, United Neemol). The company publicly reports 100% on-time clinical study completion in 2022 and 96% in 2021, and has held Crédit Impôt Recherche approval since 2010.

Name

Slb Pharma

Legal name

SLB Pharma

Website

https://slbpharma.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

SLB Pharma is a privately held French CRO founded in 2007 and headquartered in Rennes, providing clinical research services for medical device manufacturers, decentralized clinical trials, and nutraceutical sponsors across European markets.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417), Medical and Diagnostic Laboratories (6215)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF)

Keywords

• Clinical research services
• Medical device investigations
• Decentralized clinical trials
• Nutraceutical clinical studies
• Contract research organization

Headquarters

HQ city

Rennes-les-bains

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Research Services (CRO): Full-service CRO providing clinical research services for medical devices, nutraceuticals, and pharmaceutical products. Services include study design, regulatory submissions, clinical monitoring, data management, biostatistics, and scientific valorization. Revenue is generated through project-based professional service contracts with healthcare product manufacturers seeking clinical validation and regulatory approvals.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

SLB Pharma is a French Contract Research Organization (CRO) providing full-service clinical research for medical devices, decentralized clinical trials, and nutraceuticals. Services span study design, regulatory submissions (ANSM, CPP, CNIL), investigator network selection, clinical monitoring, data management, biostatistics, and scientific valorization for health product manufacturers seeking CE marking under EU MDR, post-market clinical follow-up, and clinical claims evidence.

Product overview

SLB Pharma is a full-service Contract Research Organization (CRO) providing comprehensive clinical research services. The company operates as a unified service platform offering medical device clinical investigation, decentralized clinical trials (ECDs), and nutraceutical clinical studies. Core offerings include study design and methodology, regulatory submissions (ANSM, CPP, CNIL), investigator network selection, clinical monitoring, data management with biostatistics, and scientific communication. The company also provides an eCRF (electronic Case Report Form) platform for data collection.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Services (CRO) Full-service Contract Research Organization (CRO) services for health product manufacturers covering study design and methodology, regulatory submissions (ANSM, CPP, CNIL), investigator network selection, clinical monitoring, data management, biostatistics, and scientific valorization/publications across medical device, decentralized clinical trial, and nutraceutical sponsors.
• Medical Device Clinical Investigation Clinical investigation services for medical devices covering pre-CE marking through post-market clinical follow-up (SCAC), supporting performance and safety evaluations under EU MDR 2017/745 for medical device manufacturers.
• Decentralized Clinical Trials (ECDs) Remote clinical trial execution services including satellite sites, patient home visits, telemedicine consultations, electronic consent (eConsent), digital patient questionnaires (ePRO), and connected medical device telemonitoring for sponsors seeking decentralized protocols.
• Nutraceutical Clinical Studies Clinical trials for nutraceuticals, food supplements (DADFMS), and dietary products evaluating efficacy, safety, and tolerance, supporting health claims for EFSA submissions or HAS reimbursement dossiers for food industry and dietary supplement manufacturers.
• eCRF (Electronic Case Report Form) Platform Electronic data capture platform enabling real-time clinical study data collection and management across investigator sites, used to support SLB Pharma's clinical research service delivery.

Quantifiable outcome

• 100% of clinical studies conducted in 2022 were completed on schedule or ahead of time; 96% achieved this in 2021

Named customers16 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered minor.

• Santé BrassardsminorGTM or Marketing Partner · 1 January 2022SLB Pharma supports the student health association Santé Brassards from Rennes 1 university for the Course Croisière EDHEC (CCE), Europe's largest student sailing event. This partnership connects to SLB Pharma's Breton identity as several team members are alumni of Rennes 1 university.
• Dopamine Sailing Team / Florian GueguenminorGTM or Marketing Partner · 1 January 2020SLB Pharma sponsors Florian Guegen, a sailor from Cancale, who competes under the Dopamine Sailing Team name supporting the France Parkinson association. The sponsorship began in 2018 for the Route du Rhum and continued for subsequent races including Transat Jacques Vabre and Route du Rhum 2022. Florian's grandfather suffers from Parkinson's disease, making this cause medically relevant to SLB Pharma's clinical research activities in neurology.
• France ParkinsonminorGTM or Marketing PartnerFrench association supporting Parkinson's disease patients. Florian Gueguen's sailing team raises awareness for this disease. SLB Pharma's CEO has personal connection to neurology through her thesis director Pr Hervé Allain, a prominent Parkinson's researcher.
• AFCROsminorOthersFrench clinical research association network. SLB Pharma is a member of this professional organization connecting French CROs and clinical research professionals.
• Atlanpole BiothérapiesminorOthersRegional biotechnology cluster in the Pays de la Loire and Brittany regions. SLB Pharma participates in this network of biotech and health companies.
• Biotech Santé BretagneminorOthersRegional biotech and health industry cluster in Brittany. SLB Pharma is a member supporting the biotech ecosystem in its home region.
• Clubster Nutrition Santé LongévitéminorOthersRegional cluster focused on nutrition, health, and longevity. Directly relevant to SLB Pharma's nutraceutical business unit.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Excelya: Excelya is a European-headquartered mid-size CRO formed from the consolidation of multiple French/European CROs, offering biostatistics, clinical operations, and regulatory services. It is one of the few European mid-market CROs at comparable scale, making it a close competitor for French and EU medical-device and nutraceutical contracts.
• NAMSA: NAMSA is one of the most specialized medical device CROs globally, offering regulatory, clinical, and laboratory services for device manufacturers. It is the closest pure-play comparison for SLB Pharma's medical-device clinical investigation practice and the most relevant global benchmark for an investor thesis on a device-focused CRO.
• Biotrial: Biotrial is a France-based CRO with a comparable private, mid-size profile. While anchored in early-phase clinical research, its Phase I–IV clinical operations overlap directly with SLB Pharma's medical-device and nutraceutical trial work, and both compete for French/European sponsor engagements.
• Keyrus Life Sciences: Keyrus Life Sciences is the CRO arm of the French consultancy Keyrus, providing clinical operations, biostatistics, and data management services across Europe. It competes with SLB Pharma for mid-market French and European clinical research contracts, especially in medical device and life sciences.
• Clinipace Worldwide (now Worldwide Clinical Trials): Worldwide Clinical Trials is a mid-size, mid-tier CRO offering Phase II–IV and post-approval clinical services to mid-market sponsors in medical device and specialty therapeutics. It is comparable to SLB Pharma in size and target sponsor segment, while operating with broader geographic reach.
• Eurofins Clinical Research Services: Eurofins CRO (formerly Optimed) is a French-rooted CRO that, like SLB Pharma, delivers clinical investigations for medical devices and nutraceuticals in Europe. It competes head-to-head for European medical-device CE-marking and post-market studies while offering deeper bench, making it the most directly comparable European clinical CRO peer.

Broad incumbents

• Medpace: Medpace is a large, publicly-traded, full-service CRO with strong global footprint and growing medical-device activities. It competes with SLB Pharma for the same medical-device sponsors at the upper end of contract size while bringing regulatory, biostatistics, and laboratory capabilities SLB Pharma cannot match.
• Syneos Health: Syneos Health is a global full-service CRO that delivers clinical development and post-approval services across therapeutic areas and device categories. It competes for many of the same medical-device and specialty sponsors but at greater scale and global reach.
• IQVIA: IQVIA is the world's largest CRO and clinical research services provider, with extensive medical-device and DCT capabilities. It represents the dominant incumbent alternative for enterprise sponsors evaluating SLB Pharma on competitive bids.
• Charles River Laboratories: Charles River is a global CRO and preclinical/clinical research provider, including medical-device safety and clinical services. It is a scaled incumbent whose breadth and balance-sheet allow it to compete for the same European device and nutraceutical sponsors as SLB Pharma.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/slb-pharma

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Slb Pharma